High flow oxygen, which is currently under clinical trial for treatment of vaso-occlusive pain crisis in SCD patients,44 has been shown to increase SOD2 activity in macrophages.45 Unfortunately, we are unaware if hyperoxic treatment was used by the patients in this study. Here, SOD2 is linked to Schnyder corneal dystrophy.